237 related articles for article (PubMed ID: 16301596)
1. Acute chemotherapy-induced cardiovascular changes in patients with testicular cancer.
Nuver J; Smit AJ; van der Meer J; van den Berg MP; van der Graaf WT; Meinardi MT; Sleijfer DT; Hoekstra HJ; van Gessel AI; van Roon AM; Gietema JA
J Clin Oncol; 2005 Dec; 23(36):9130-7. PubMed ID: 16301596
[TBL] [Abstract][Full Text] [Related]
2. Acute chemotherapy-induced cardiovascular changes in patients with testicular cancer: are there implications for blood pressure management in patients receiving chemotherapy?
Kohli S; Kohli M
J Clin Oncol; 2006 May; 24(15):2399; author reply 2399-400. PubMed ID: 16710045
[No Abstract] [Full Text] [Related]
3. Left ventricular and cardiac autonomic function in survivors of testicular cancer.
Nuver J; Smit AJ; Sleijfer DT; van Gessel AI; van Roon AM; van der Meer J; van den Berg MP; Hoekstra HJ; Sluiter WJ; Gietema JA
Eur J Clin Invest; 2005 Feb; 35(2):99-103. PubMed ID: 15667580
[TBL] [Abstract][Full Text] [Related]
4. Completion and toxicity of induction chemotherapy for metastatic testicular cancer: an updated evaluation of Japanese patients.
Kawai K; Ando S; Hinotsu S; Oikawa T; Sekido N; Miyanaga N; Shimazui T; Akaza H
Jpn J Clin Oncol; 2006 Jul; 36(7):425-31. PubMed ID: 16790450
[TBL] [Abstract][Full Text] [Related]
5. Vascular fingerprint and vascular damage markers associated with vascular events in testicular cancer patients during and after chemotherapy.
Lubberts S; Boer H; Altena R; Meijer C; van Roon AM; Zwart N; Oosting SF; Kamphuisen PW; Nuver J; Smit AJ; Mulder AB; Lefrandt JD; Gietema JA
Eur J Cancer; 2016 Aug; 63():180-8. PubMed ID: 27322917
[TBL] [Abstract][Full Text] [Related]
6. Recent advances in the treatment of testicular cancer.
Huddart RA; Birtle AJ
Expert Rev Anticancer Ther; 2005 Feb; 5(1):123-38. PubMed ID: 15757445
[TBL] [Abstract][Full Text] [Related]
7. History of testicular cancer chemotherapy: maximizing efficacy, minimizing toxicity.
Sweeney C
Semin Urol Oncol; 2001 Aug; 19(3):170-9. PubMed ID: 11561984
[TBL] [Abstract][Full Text] [Related]
8. Management of good risk germ-cell tumours.
Troost MM; Sternberg CN; de Wit R
BJU Int; 2009 Nov; 104(9 Pt B):1387-91. PubMed ID: 19840018
[TBL] [Abstract][Full Text] [Related]
9. Acute myocardial infarction during combined chemotherapy with bleomycin, etoposide and cisplatin for testicular cancer.
Shoji S; Miyakita H; Shima M; Usui Y; Nagata Y; Uchida T; Terachi T
Hinyokika Kiyo; 2006 Sep; 52(9):723-6. PubMed ID: 17040060
[TBL] [Abstract][Full Text] [Related]
10. [Chemotherapy of testicular cancer].
Witjes JA; Debruyne FM
Ned Tijdschr Geneeskd; 1999 Mar; 143(11):557-60. PubMed ID: 10321273
[TBL] [Abstract][Full Text] [Related]
11. Long-term risk of cardiovascular disease in 5-year survivors of testicular cancer.
van den Belt-Dusebout AW; Nuver J; de Wit R; Gietema JA; ten Bokkel Huinink WW; Rodrigus PT; Schimmel EC; Aleman BM; van Leeuwen FE
J Clin Oncol; 2006 Jan; 24(3):467-75. PubMed ID: 16421423
[TBL] [Abstract][Full Text] [Related]
12. Impaired flow-mediated vasodilation, carotid artery intima-media thickening, and elevated endothelial plasma markers in obese children: the impact of cardiovascular risk factors.
Meyer AA; Kundt G; Steiner M; Schuff-Werner P; Kienast W
Pediatrics; 2006 May; 117(5):1560-7. PubMed ID: 16651309
[TBL] [Abstract][Full Text] [Related]
13. [Randomized phase III study on nonseminomatous testicular tumor].
Rexer H
Urologe A; 2004 Nov; 43(11):1432-3. PubMed ID: 15526083
[No Abstract] [Full Text] [Related]
14. Acute anterior myocardial infarction after chemotherapy for testicular seminoma in a young patient.
Ozben B; Kurt R; Oflaz H; Sezer M; Basaran M; Goren T; Umman S
Clin Appl Thromb Hemost; 2007 Oct; 13(4):439-42. PubMed ID: 17911198
[TBL] [Abstract][Full Text] [Related]
15. Long-term followup results of 1 cycle of adjuvant bleomycin, etoposide and cisplatin chemotherapy for high risk clinical stage I nonseminomatous germ cell tumors of the testis.
Westermann DH; Schefer H; Thalmann GN; Karamitopoulou-Diamantis E; Fey MF; Studer UE
J Urol; 2008 Jan; 179(1):163-6. PubMed ID: 18001800
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular risk in long-term survivors of testicular cancer.
Vaughn DJ; Palmer SC; Carver JR; Jacobs LA; Mohler ER
Cancer; 2008 May; 112(9):1949-53. PubMed ID: 18338810
[TBL] [Abstract][Full Text] [Related]
17. Cisplatin based chemotherapy in testicular cancer patients: long term platinum excretion and clinical effects.
Hohnloser JH; Schierl R; Hasford B; Emmerich B
Eur J Med Res; 1996 Sep; 1(11):509-14. PubMed ID: 9438151
[TBL] [Abstract][Full Text] [Related]
18. Cognitive complaints and cognitive impairment following BEP chemotherapy in patients with testicular cancer.
Schagen SB; Boogerd W; Muller MJ; Huinink WT; Moonen L; Meinhardt W; Van Dam FS
Acta Oncol; 2008; 47(1):63-70. PubMed ID: 17934892
[TBL] [Abstract][Full Text] [Related]
19. Increase in carotid artery intima-media thickness and arterial stiffness but improvement in several markers of endothelial function after initiation of antiretroviral therapy.
van Vonderen MG; Hassink EA; van Agtmael MA; Stehouwer CD; Danner SA; Reiss P; Smulders Y
J Infect Dis; 2009 Apr; 199(8):1186-94. PubMed ID: 19275490
[TBL] [Abstract][Full Text] [Related]
20. Variation in bleomycin hydrolase gene is associated with reduced survival after chemotherapy for testicular germ cell cancer.
de Haas EC; Zwart N; Meijer C; Nuver J; Boezen HM; Suurmeijer AJ; Hoekstra HJ; van der Steege G; Sleijfer DT; Gietema JA
J Clin Oncol; 2008 Apr; 26(11):1817-23. PubMed ID: 18398146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
